Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2024-09-23 13:50 Tx date 2024-09-20 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,000
+66,667 vol $0.24 each |
313,333 | |
Filed 2024-09-23 13:50 Tx date 2024-09-20 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-66,667 vol |
66,667 | |
Filed 2024-09-23 09:56 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-66,667 vol |
||
Filed 2024-09-23 09:56 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,000
+66,667 vol $0.24 each |
||
Filed 2024-09-20 20:04 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,000
+66,667 vol $0.24 each |
||
Filed 2024-09-20 20:03 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-66,667 vol |
||
Filed 2024-09-20 20:04 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$16,000
+66,667 vol $0.24 each |
313,333 | |
Filed 2024-09-20 20:03 Tx date 2024-09-16 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-66,667 vol |
66,667 | |
Filed 2024-03-28 10:34 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+180,000 vol |
246,666 | |
Filed 2024-03-28 10:34 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+66,666 vol |
66,666 | |
Filed 2024-03-28 10:33 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-03-28 10:33 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-180,000 vol |
133,334 | |
Filed 2024-03-28 10:33 Tx date 2024-03-25 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-66,666 vol |
313,334 | |
Filed 2024-03-18 11:55 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+180,000 vol |
380,000 | |
Filed 2024-03-18 11:54 Tx date 2024-03-14 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+200,000 vol |
200,000 | |
Filed 2024-03-18 11:54 Tx date 2019-09-25 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-08-15 15:00 Tx date 2023-08-11 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
+225,000 vol |
925,000 | |
Filed 2021-09-27 04:49 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$88,500
+150,000 vol $0.59 each |
||
Filed 2021-09-27 04:43 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$88,500
+150,000 vol $0.59 each |
||
Filed 2021-09-13 05:06 Tx date 2021-09-02 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$88,500
+150,000 vol $0.59 each |
700,000 | |
Filed 2021-09-13 05:05 Tx date 2021-03-15 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$61,499
+150,000 vol $0.41 each |
550,000 | |
Filed 2021-09-13 05:05 Tx date 2020-07-02 |
$INNO
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
50 - Grant of options
|
$16,000
+100,000 vol $0.16 each |
400,000 | |
Filed 2019-10-06 10:32 Tx date 2019-09-25 |
$
InnoCan Pharma Corporation |
Bossino, Ralph
4 - Director of Issuer, 6 - Director or Senior Officer of 10% Security Holder
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
300,000 |